MabGenesis Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
Expected Date |
| 653A |
Pharmaceuticals |
Growth |
Tokai Tokyo Securities Co., Ltd |
2026/09/28 |
2026/11/02 |
| 【Description】 |
| |
IPO Information |
| Listed Shares(total) |
1,987,900 |
Trading Unit |
100 |
| New Shares |
940,700 |
Existing Shares |
1,047,200 |
| Shares Outstanding |
Pre IPO |
7,114,000.00 |
| PostIPO |
8,054,700.00 |
| Paid Up Capital |
PreIPO |
Y90,000,000 |
| PostIPO |
|
| Expected Pricing Date |
2026/10/13 |
| Book Building Start |
2026/10/15 |
Book Building End |
2026/10/21 |
| Fix Date |
2026/10/22 |
| Offering Starts |
2026/10/23 |
Offering Ends |
2026/10/28 |
| Expect Pricing |
|
Notional PER
(based on previous period) |
|
| Offering Price |
|
Offering Price PER
(based on previous period) |
|
Offering Price PBR
(based on previous period) |
|
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2024/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
66,161 |
-147,911 |
-148,215 |
165,888 |
| 2025/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
144,459 |
-103,525 |
-103,830 |
532,058 |
| 2026/03 |
Consolidated |
- |
- |
- |
- |
| Consolidated |
337,548 |
36,436 |
36,131 |
568,190 |
Recent Quarter
2026/06 |
Consolidated |
- |
- |
- |
- |
| Consolidated |
41,857 |
-36,894 |
-36,970 |
531,219 |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2024/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
-24.96 |
-111.20 |
|
| 2025/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
-16.60 |
-138.42 |
|
| 2026/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
5.08 |
-128.95 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2026/06 |
Non-consolidated |
|
- |
- |
|
| Consolidated |
-5.20 |
- |
|
Comment |
| ■Over allotment (298,000) |
Consolidated Subsidiaries |
| Name |
Address |
Underwriters |
| Allocation |
Underwriter |
Tel |
| 0% |
Tokai Tokyo Securities Co., Ltd |
03-3566-8811 |
| 0% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 0% |
Marusan Securities Co., Ltd |
03-3272-5211 |
| 0% |
Monex, Inc |
03-4323-3800 |
Data |
| Date of incorporation |
2019/06/03 |
| Company address |
Kanagawa 222-0033 |
| Telephone |
045-534-6033 |
| President |
|
| Homepage |
https://mabgenesis.com/ |
| Auditor |
BDO Sanyu & Co |
|
|
Major Shareholders |
| Shareholder Name |
Ratio |
| |
15.96% |
| |
13.03% |
| |
12.43% |
| |
12.12% |
| |
8.14% |
| |
6.64% |
| |
6.51% |
| |
6.25% |
| |
4.40% |
| |
3.26% |
| Number of Employees |
15 as of 2026/08/31 |
| Birth Date of Representative |
1960/03/29 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
